Antimicrobial peptide LL-37 promotes proliferation of human bone marrow-derived mesenchymal stem cells
4 affiliations
- 1Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Chiang Mai University
- 2Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University
- 3Department of Oral Biology and Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University
- 4Biomedical Engineering Institute, CMU-BIOPOLIS building, Chiang Mai University– Mae Hia campus
Abstract
Human cathelicidin (LL-37), a pleiotropic host defense peptide, plays a pivotal role in orchestrating tissue repair, immunomodulation, and angiogenesis. It has been known to regulate the proliferation of mesenchymal stem cells (MSCs) derived from human adipose tissues, apical papilla, and dental pulp tissues, which are considered promising sources for bone regeneration. However, its effects on human bone marrow-derived MSCs (hBM-MSCs) and the underlying molecular mechanisms have not been fully investigated. This study evaluated the effects of LL-37 on hBM-MSCs proliferation and elucidated the transcriptomic landscape governing this response. The hBM-MSCs were isolated, cultured, and characterized based on their surface marker and multilineage differentiation potential. The cells were treated with various concentrations of LL-37 to evaluate proliferation. The results showed that LL-37 has a biphasic impact on hBM-MSCs kinetics, in which 2 µM of LL-37 markedly enhances proliferation, whereas supraphysiological levels (20 µM) cause cytotoxicity. RNA sequencing analysis suggested upregulation of proliferation-related genes in LL-37–treated hBM-MSCs, particularly AKT3. Mechanistic validation through Western blotting confirmed that LL-37 treatment could enhance AKT3 expression and AKT phosphorylation. Inhibition of AKT phosphorylation by chemical inhibitors attenuated LL-37 induced cell proliferation. These findings indicate LL-37 as a potent bioactive modulator of hBM-MSCs proliferation, with mechanistic evidence suggesting the involvement of the AKT signalling pathway, and support its potential application in bone regeneration.
Related
- M2 type tumor-associated macrophage-derived CCL-18 promotes glioma cell proliferation but does not mediates glioma recurrence after radiotherapy
- SDF-1 promotes migration, proliferation, and epithelial-mesenchymal plasticity of hepatocellular carcinoma cells via CXCR4-mediated histone deacetylation
- Localized transplantation of periodontal ligament-derived mesenchymal stromal cell sheets promotes mandibular wound healing in zoledronate-treated beagle dogs
- Combined effects of 450, 635 and 980 nm LASER wavelengths on proliferation and migration of human periodontal ligament mesenchymal stem cells
- UCHL1 Promotes Epithelial–Mesenchymal Transition Through E-Cadherin and N-Cadherin Switch in Endometrial Cancer
BibTeX
@article{pinthonglor2026antimicrobial,
title = {{Antimicrobial peptide LL-37 promotes proliferation of human bone marrow-derived mesenchymal stem cells}},
author = {Putida Pinthonglor and Pareena Chotjumlong and Dumnoensun Pruksakorn and Jeerawan Klangjorhor and Patcharawadee Thongkumkoon and Worakanya Buranaphatthana and Sarawut Kumphune and Chayarop Supanchart},
journal = {Scientific Reports},
year = {2026},
month = jul,
doi = {10.1038/s41598-026-63881-6},
url = {https://doi.org/10.1038/s41598-026-63881-6},
note = {CC BY},
}
RIS
TY - JOUR
TI - Antimicrobial peptide LL-37 promotes proliferation of human bone marrow-derived mesenchymal stem cells
AU - Putida Pinthonglor
AU - Pareena Chotjumlong
AU - Dumnoensun Pruksakorn
AU - Jeerawan Klangjorhor
AU - Patcharawadee Thongkumkoon
AU - Worakanya Buranaphatthana
AU - Sarawut Kumphune
AU - Chayarop Supanchart
PY - 2026
DA - 2026/07/01
JO - Scientific Reports
DO - 10.1038/s41598-026-63881-6
UR - https://doi.org/10.1038/s41598-026-63881-6
AB - Human cathelicidin (LL-37), a pleiotropic host defense peptide, plays a pivotal role in orchestrating tissue repair, immunomodulation, and angiogenesis. It has been known to regulate the proliferation of mesenchymal stem cells (MSCs) derived from human adipose tissues, apical papilla, and dental pulp tissues, which are considered promising sources for bone regeneration. However, its effects on human bone marrow-derived MSCs (hBM-MSCs) and the underlying molecular mechanisms have not been fully investigated. This study evaluated the effects of LL-37 on hBM-MSCs proliferation and elucidated the transcriptomic landscape governing this response. The hBM-MSCs were isolated, cultured, and characterized based on their surface marker and multilineage differentiation potential. The cells were treated with various concentrations of LL-37 to evaluate proliferation. The results showed that LL-37 has a biphasic impact on hBM-MSCs kinetics, in which 2 µM of LL-37 markedly enhances proliferation, whereas supraphysiological levels (20 µM) cause cytotoxicity. RNA sequencing analysis suggested upregulation of proliferation-related genes in LL-37–treated hBM-MSCs, particularly AKT3. Mechanistic validation through Western blotting confirmed that LL-37 treatment could enhance AKT3 expression and AKT phosphorylation. Inhibition of AKT phosphorylation by chemical inhibitors attenuated LL-37 induced cell proliferation. These findings indicate LL-37 as a potent bioactive modulator of hBM-MSCs proliferation, with mechanistic evidence suggesting the involvement of the AKT signalling pathway, and support its potential application in bone regeneration.
SN - 2045-2322
ER -